首页 | 本学科首页   官方微博 | 高级检索  
     

非小细胞肺癌动态增强磁共振成像参数与血清PCNA、Survivin及VEGF表达的相关性研究
引用本文:韩松岩,赵楠,李丹. 非小细胞肺癌动态增强磁共振成像参数与血清PCNA、Survivin及VEGF表达的相关性研究[J]. 中国医学装备, 2022, 0(2): 72-76
作者姓名:韩松岩  赵楠  李丹
作者单位:盘锦市中心医院放射线科
基金项目:辽宁省科学计划项目(201703A201)“动态增强磁共振成像与非小细胞肺癌肺癌细胞相关性研究”。
摘    要:目的:研究分析非小细胞肺癌(NSCLC)患者动态增强磁共振成像(DCE-MRI)定量参数与血清增殖细胞核抗原(PCNA)、凋亡抑制蛋白(Survivin)和血管内皮生长因子(VEGF)表达水平的相关性.方法:选取医院收治的137例NSCLC患者纳入观察组,另选同期进行体检的137名健康者纳入健康对照组.采用磁共振扫描仪...

关 键 词:动态增强磁共振成像(DCE-MRI)  非小细胞肺癌(NSCLC)  增殖细胞核抗原(PCNA)  凋亡抑制蛋白(Survivin)  血管内皮生长因子(VEGF)

A relevant research between DCE-MRI parameters and expressions of PCNA,survivin and VEGF in NSCLC
HAN Song-yan,ZHAO Nan,LI Dan. A relevant research between DCE-MRI parameters and expressions of PCNA,survivin and VEGF in NSCLC[J]. China Medical Equipment, 2022, 0(2): 72-76
Authors:HAN Song-yan  ZHAO Nan  LI Dan
Affiliation:(Department of Radiology,Panjin Central Hospital,Panjin 124101,China)
Abstract:Objective:To research and analyze the correlations between quantitative parameters of dynamic contrastenhanced magnetic resonance imaging(DCE-MRI)and the expressions of proliferating cell nuclear antigen(PCNA),apoptotic inhibitor protein(Survivin),vascular endothelial growth factor(VEGF)in serum of patients with non-small cell lung cancer(NSCLC).Methods:137 patients with NSCLC who admitted to hospital were divided into observation group,and 137 healthy people who underwent physical examination in the same period were divided into healthy control group.The magnetic resonance(MR)scanner was adopted to detect transfer constant of volume(Ktrans),speed constant(Kep)and the volume ratio between extravascular and extracellular interval(Ve)of DCE-MRI quantitative parameters.The enzyme linked immunosorbent assay(ELISA)was adopted to detect the levels of serum PCNA,Survivin and VEGF of two groups,and the Ktrans,Kep and Ve of DCE-MRI were compared and analyzed.And the relations of the expression levels of serum,Ktrans,Kep and Ve and clinicopathologic features of observation group were analyzed.The correlations of serum levels of PCNA,Survivin and VEGF and the values of Ktrans,Kep and Ve of two groups were analyzed by Pearson correlation analysis method.Results:The levels of serum PCNA,Survivin and VEGF of observation group were significantly higher than those of healthy control group(t=50.025,t=8.724,t=16.330,P<0.05),respectively.And the values of Ktrans,Kep and Ve of observation group were significantly higher than those of healthy control group(t=8.258,t=7.937,t=14.046,P<0.05).In the observation group,the expression levels of serum PCNA,Survivin and VEGF of minor differentiation,TNM III stage and lymphatic metastasis were significantly higher than those of high-middle differentiation,TNM I-II stage and nonlymphatic metastasis(tPCNA=4.192,t=4.327,t=5.857,tSurvivin=3.197,t=3.428,t=5.140,tVEGF=4.915,t=4.724,t=4.485,P<0.05),respectively.The values of Ktrans,Kep and Ve of minor differentiation,TNM III stage and lymphatic metastasis were significantly higher than those of high-middle differentiation,TNM I-II stage and non-lymphatic metastasis(tKtrans=5.159,t=5.514,t=4.841,tKep=6.043,t=5.776,t=5.690,tVe=5.265,t=6.076,t=6.783,P<0.05),respectively.In observation group,the expression levels of serum PCNA and Survivin were positive correlation with the values of Ktrans and Kep(rPCNA=0.435,r=0.402,rSurvivin=0.382,r=0.393,P<0.05),and the expression level of VEGF was positive correlation with the values of Ktrans,Kep and Ve(r=0.503,r=0.405,r=0.316,P<0.05),respectively.Conclusion:There are a certain of correlations between DCE-MRI quantitative parameters and the serum PCNA,Survivin and VEGF in NSCLC patients,and the DCE-MRI quantitative parameters and the detections of serum PCNA,Survivin and VEGF have a certain of reference value in judging the state of disease and assessing the prognosis for patients.
Keywords:Dynamic contrast-enhancement magnetic resonance imaging(DCE-MRI)  Non-small cell lung cancer(NSCLC)  Proliferating cell nuclear antigen(PCNA)  Survivin  Vascular endothelial growth factor(VEGF)
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号